By Kat Greene ( October 3, 2016, 6:35 PM EDT) -- Puma Biotechnology Inc. will have to face a proposed class action for allegedly misleading investors about a breast cancer drug, a California federal judge ruled in an order Friday that also included some criticism for the way defense attorneys have employed judicial notice requests....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.